Institutional members access full text with Ovid®

Share this article on:

Dabigatran etexilate (Pradaxa) for the treatment of atrial fibrillation

Belavic, Jennifer M. PharmD, FASCP

doi: 10.1097/01.NPR.0000403296.82092.fb
Department: Drug News

Jennifer M. Belavic is a clinical pharmacist in the Trauma Intensive Care Unit, University of Pittsburgh Medical Center, Presbyterian Hospital, Pitsburgh.

The author has disclosed that she has no financial relationships pertaining to this article.

© 2011 Lippincott Williams & Wilkins, Inc.